Elucidating the role of incidental use of beta-blockers in patients with metastatic brain tumors in controlling tumor progression and survivability

Neurology India
Shyamal C BirAnil Nanda

Abstract

Beta-adrenergic antagonists have demonstrated beneficial effects in tumor progression and survivability in patients with various cancers by inhibiting norepinephrine-induced tumor cell migration. However, little is known about their effects on the outcomes of metastatic brain tumors (MBTs). This study was undertaken to evaluate the effects of beta-blockers, if any, on the outcome of MBTs, and their possible role in controlling tumor progression and survivability. A retrospective cohort analysis of 225 patients identified as having MBTs presenting to our institution from 2001 through 2013 was conducted by reviewing electronic patient records. Patients were categorized into three groups: Group A comprised hypertensives on beta-blockers only (40, 18%), Group B comprised hypertensive patients on antihypertensive medications other than beta-agonists (65, 29%), and Group C comprised normotensives (120, 53%). All outcomes were compared using the data on pre - and post-gamma knife radiosurgery (GKRS) for these groups. One-way analysis of variance (ANOVA) was used to compare the radiological and clinical outcomes in the patient population following beta-blockers usage in Group A versus groups B and C. Cox regression model was used to de...Continue Reading

References

Feb 1, 1992·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·V LepicovskaZ Fabian
Aug 2, 2003·Breast Cancer Research and Treatment·T L DrellF Entschladen
Sep 19, 2003·Neuroimaging Clinics of North America·Alf HutterRobert C McKinstry
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Kerstin LangFrank Entschladen
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Daniel PalmFrank Entschladen
Feb 6, 2010·International Journal of Radiation Oncology, Biology, Physics·Shlomo A KoyfmanJohn H Suh
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan K LutgendorfMichael H Antoni
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A Ganz, Steven W Cole
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas I BarronKala Visvanathan
Sep 22, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Stanley LemeshowRonald Glaser
Apr 11, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Hussein A N Al-WadeiMohammed H Al-Wadei
Jan 10, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H M WangD R Gomez
Jun 29, 2013·Current Cancer Therapy Reviews·Hildegard M Schuller, Hussein A N Al-Wadei
Jul 3, 2013·Cancer Treatment Reviews·Bodo LippitzRonald Beaney
Aug 6, 2013·Breast Cancer Research and Treatment·Edoardo BotteriSara Gandini
Jul 30, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Shyamal C BirAnil Nanda

❮ Previous
Next ❯

Citations

May 18, 2016·Cancer Treatment Reviews·Janick WeberpalsHermann Brenner
Nov 25, 2018·British Journal of Pharmacology·Massimo Dal MontePaola Bagnoli
Jul 28, 2015·Open Forum Infectious Diseases·Coralie BouchiatFrançois Vandenesch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

International Journal of Breast Cancer
Athina Stravodimou, Ioannis A Voutsadakis
Japanese Journal of Cancer Research : Gann
T KuroishiS Itoh
© 2022 Meta ULC. All rights reserved